18:1 LYSO PA

Code: 857130C-200MG D2-231

Application

18:1 Lyso PA is suitable:for liposome preparationsto study its apoptotic effect in HeLa cellsto determine the extraction recovery of LPA at neutral pH and acidic ...


 Read more

Your Price
€467.91 EACH
€575.53 inc. VAT

Application

18:1 Lyso PA is suitable:for liposome preparationsto study its apoptotic effect in HeLa cellsto determine the extraction recovery of LPA at neutral pH and acidic pH by chromatographyto use as a LPA agonist supplement in oocytes maturation medium to study its effects during in vitro maturation of bovine cumulus–oocyte complexes

Biochem/physiol Actions

Lysophosphatidic acid (1- or 2-acyl-lysophosphatidic acid/LPA) modulates cell motility, proliferation, invasion, survival and production of growth factors via G protein-coupled receptor (GPCR). 1-oleoyl-lysophosphatidic acid (LPA) has the ability to stimulate tyrosine phosphorylation of numerous substrates in Swiss 3T3 cells. It also helps to release calcium from the platelet subcellular fraction.

General description

Lysophosphatidic acid (1- or 2-acyl-lysophosphatidic acid/LPA), a bioactive phospholipid is seen at a low level in plasma (~100 nM). It is usually formed during the synthesis of phospholipid of cell membranes. It is produced by various cells like, activated platelets, epithelial cells, leukocytes, neuronal cells and tumor cells.

Biological responses to LPA: Cell Proliferation, Inhibition of differentiation (neuroblastoma cells, myoblasts), Platelet aggregation, Smooth muscle contraction, Neurotransmitter release, Stress fibre formation/cell rounding/neurite retraction, Cell-surface-fibronectin binding, Tumor cell invasion, Chemotaxis (dictyostelium amoebae), Cl--mediated membrane depolarization (fibroblasts), Inhibition of connexin 43 based cell-cell communication, Increased tight junction permeability (brain endothelial cells). Note: The bioactivity of LPA appears to require long (i.e., C16 to C18) acyl carbon chains of the type usually found associated with membrane lipids although optimum requirements for a single type of acyl carbon chain are not universal. The bioactivity decreases with shorter chain length. In serum, oleoyl and palmitoyl fatty acid containing LPA are the predominant species.

Packaging

5 mL Clear Glass Sealed Ampule (857130C-25mg)

5 mL Clear Glass Sealed Ampule (857130C-200mg)

assay>99% (LPA; may contain up to 10% of the 2-LPA isomer, TLC)
concentration25 mg/mL (857130C-200mg), 10 mg/mL (857130C-25mg)
formliquid
manufacturer/tradenameAvanti Polar Lipids 857130C
packagingpkg of 1 × 2.5 mL (857130C-25mg), pkg of 2 × 4 mL (857130C-200mg)
shipped indry ice
storage temp.−20°C
Cas Number325465-93-8
This product has met the following criteria to qualify for the following awards:



HAVE AN ACCOUNT? LOGIN

GUEST CHECKOUT

Proceed as a guest. You will have the option to register to access exclusive pricing and stock availability features after checkout.